tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alethia Young, 259 are a BUY (79.94%), 59 are a HOLD (18.21%), 6 are a SELL (1.85%).
Analyst Alethia Young, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 60.96% that have a potential upside of 51.01% achieved within 367 days.
Alethia Young’s has documented 620 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 05-Jul-2024.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-May-2018
$2
$1.82 (1011.11%)
$5
6 years 9 months 2 days ago
(03-May-2019)
2/3 (66.67%)
$-0.96 (-32.43%)
528
Hold Since 04-Nov-2016
$4
7 years 11 months 28 days ago
(08-Feb-2018)
4/4 (100%)
$-0.81 (-16.84%)
106
Buy Since 11-Dec-2017
$5
$4.82 (2677.78%)
$6
8 years 1 months 25 days ago
(11-Dec-2017)
0/4 (0%)
$2.14 (74.83%)
Buy Since 15-Sep-2016
$10
8 years 4 months 24 days ago
(12-Sep-2017)
0/2 (0%)
$5.79 (137.53%)
Hold Since 10-Aug-2017
$4
$3.82 (2122.22%)
$5
8 years 4 months 25 days ago
(11-Sep-2017)
6/7 (85.71%)
$0.17 (4.44%)
49
What Year was the first public recommendation made by Alethia Young?
